SOD2 and diabetic cardiomyopathy: Additionally, in an in vivo model of streptozotocin‐induced hyperglycemia and diabetes type I in rats, CV showed beneficial effects on diabetic cardiomyopathy and increased protein expression of SOD2, SOD1, and catalase in heart and skeletal muscle [35].